Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis

Original Article

R.A. Furie, B.H. Rovin, J.P. Garg, M.B. Santiago, G. Aroca-Martínez, A.E.Z. Santillán, D. Alvarez, C.N. Sandoval, A.M. Lila, J.A. Tumlin, A. Saxena, F.I. Palazuelos, H. Raghu, B. Yoo, I. Hassan, E. Martins, H. Sehgal, P. Kirchner, J.R. Terres, T.A. Omachi, T. Schindler, W.F.P. III III, and A. Malvar

N Engl J Med 2025;392:1471-1483

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
04/16/2025
Course expires: 
04/17/2027

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Please sign in or create an account to take the course.